Shanghai Rendu Biotechnology Co

Shanghai Rendu Biotechnology Co Days Payable Outstanding

The Days Payable Outstanding (DPO) of Shanghai Rendu Biotechnology Co (688193.SS) as of Oct 29, 2026 is 27.68. In the previous year, Days Payable Outstanding (DPO) was 30.48 — a change of -9.18% (lower).

Days Payable Outstanding

27.68

YoY

-9.18%

Last updated:

Days Payable Outstanding (DPO) of Shanghai Rendu Biotechnology Co is 2025 27.68 . Days Payable Outstanding (DPO) of Shanghai Rendu Biotechnology Co was 2024 30.48 . It decreases by -9.18% lower compared to the previous year.

The Shanghai Rendu Biotechnology Co Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
104.60 CNY
Jan 1, 2019
73.84 CNY
Jan 1, 2020
48.20 CNY
Jan 1, 2021
48.41 CNY
Jan 1, 2022
39.66 CNY
Jan 1, 2023
48.49 CNY
Jan 1, 2024
30.48 CNY
Jan 1, 2025
27.68 CNY
The Shanghai Rendu Biotechnology Co Days Payable Outstanding history
YEARDays Payable OutstandingYoY
27.68-9.18%
30.48-37.14%
48.49+22.26%
39.66-18.08%
48.41+0.45%
48.20-34.73%
73.84-29.40%
104.60—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co., Ltd. generates revenue through the sale of molecular diagnostic tests and medical instruments. The company develops diagnostic reagents using RNA isothermal amplification technology, including respiration series, reproduction series, enterovirus series, and blood-borne diseases series. These products are sold domestically within China, targeting healthcare providers and laboratories that require rapid and accurate diagnostic solutions. The firm's focus on domestic market sales ensures consistent demand for its specialized reagents and instruments. The company's product portfolio includes multiple series of diagnostic reagents designed for specific health conditions, such as respiratory and reproductive health. Medical instruments are also manufactured and sold alongside these reagents. Domestic sales within China form the primary revenue stream, with no mention of international markets or additional product lines. The firm's technology and product offerings cater to the needs of medical professionals seeking efficient diagnostic tools. Shanghai Rendu Biotechnology's business model relies on the domestic market for all product sales, with no indication of export or international partnerships. The company's workforce of 528 full-time employees supports the development, manufacturing, and sales of its diagnostic reagents and instruments. Revenue is derived solely from the sale of these products within China, without any reference to third-party collaborations or additional services. Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

Days Payable Outstanding (DPO) of Shanghai Rendu Biotechnology Co is 27.68 in 2025.

Days Payable Outstanding (DPO) of Shanghai Rendu Biotechnology Co changed from 30.48 to 27.68, representing a -9.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Shanghai Rendu Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Shanghai Rendu Biotechnology Co

All Key Metrics — Shanghai Rendu Biotechnology Co